Market Moves
Science Corp. Hits $1.25B Valuation on $230M Raise for Blindness Implant
The neurotechnology company founded by Neuralink co-founder Max Hodak has raised $230 million at a $1.25 billion valuation, bringing its total funding to $489 million as it pushes toward commercialization of its retinal implant.